Atlas Trials

Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ)

Clinical trial NCT04002687 · COMPLETED

Trial details

NCT number
NCT04002687
Sponsor
Medicines for Malaria Venture
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2019-04-04
Primary completion
2019-10-29
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.